Human medicines European public assessment report (EPAR): Tyverb, lapatinib, Breast Neoplasms, Date of authorisation: 10/06/2008, Revision: 31, Status: Authorised

SEMrush
Human medicines European public assessment report (EPAR): Tyverb, lapatinib, Breast Neoplasms, Date of authorisation: 10/06/2008, Revision: 31, Status: Authorised
[automaticbacklinks]